Experimental drug AMG 420 tested in Tough-to-Treat myeloma patients
NCT ID NCT03836053
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This early-stage study tested the drug AMG 420 in 23 people with multiple myeloma that had returned or stopped responding to at least three prior treatments. The goal was to find a safe dose and check for side effects. The study was stopped early, and results focused on safety and tumor response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advocate Lutheran General Hospital
Park Ridge, Illinois, 60068, United States
-
Centre Hospitalier Universitaire Dinant Godinne - Universite Catholique de Louvain Namur
Yvoir, 5530, Belgium
-
Centres Hospitaliers Jolimont - Hopital de Jolimont
Haine Saint Paul - La Louviere, 7100, Belgium
-
Kantonsspital St Gallen
Sankt Gallen, 9007, Switzerland
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
National Hospital Organization Okayama Medical Center
Okayama, Okayama-ken, 701-1192, Japan
-
St Vincents Hospital Melbourne
Fitzroy, VIC, Victoria, 3065, Australia
-
St Vincents Hospital Sydney
Darlinghurst, New South Wales, 2010, Australia
-
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.